Kalkine has a fully transformed New Avatar.
Seven West Media Ltd
SWM Details
· Scandal hurting the stock sentiment:Seven West Media Ltd (ASX: SWM) stock lost over 7.9% on December 19, 2016 due to news relating to a possible scandal involving key person of the group’s management. Tim Worner, the group’s CEO faced allegations of having an affair with a colleague who later got a huge financial settlement. But, the group reported that Tim Worner would remain in the CEO role. Moreover, management revealed that this settlement deed was approved by the relevant board committee.
· Recommendation: SWM stock recovered over 19.9% in the last four weeks (as at December 16, 2016). We give a “Hold” recommendation at the current price of – $ 0.75
Sirtex Medical Ltd
SRX Details
· CEO’s temporary leave added to the stock decline: Sirtex Medical Ltd (ASX: SRX) stock lost over 4% on December 19, 2016 while the group has engaged its legal advisers, Watson Mangioni, to coordinate an investigation into the share trading by CEO, Gilman Wong in October 2016. Mr Wong has taken a temporary leave until the investigation regarding his possible wrong-doing is completed.
· Recommendation: SRX stock lost over 45% in the last four weeks (as of December 16, 2016) due to the group’s lower than estimated performance in Americas and EMEA regions as per their recent trading update. On the other hand, the group forecasts a better second half of 2017 performance. We give a “Hold” recommendation at the current price of - $ 14.94
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in: BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.